The Valvular Interventions Center

Filter Your Results

 

News

 

Current TAVR Devices

Denise Todaro, MD; Andrea Picci, MD; and Marco Barbanti, MD

March/April 2017—Technical characteristics and evidence to date for FDA- and CE Mark-approved valves.

Feasibility Study Evaluates HLT’s Meridian TAVR Device and Pathfinder II Delivery System

April 10, 2017 -- HLT, Inc. recently announced the first patient enrollments in a feasibility clinical study to assess the safety and performance outcomes of the company's…

NVT AG’s Allegra Transcatheter Aortic Valve Receives CE Mark Approval

April 3, 2017 -- NVT AG recently announced that it has obtained CE mark approval for its Allegra Transcatheter Aortic Valve (TAVR) system. According to the company, the system…

Boston Scientific Agrees to Acquire Symetis

March 30, 2017 -- Boston Scientific Corporation announced a definitive agreement to acquire Symetis SA, a privately-held structural heart company based in Switzerland that is …

Medtronic's CoreValve Evolut Pro Transcatheter Valve Approved by FDA

March 23, 2017 -- Medtronic announced US Food and Drug Administration approval and the United States launch of its CoreValve Evolut Pro transcatheter valve system fo…

Study Compares TAVR Outcomes in Patients With Bicuspid and Tricuspid Aortic Stenosis

March 18, 2017 -- Patients with bicuspid aortic valve stenosis (AS) who received transcatheter aortic valve replacement (TAVR) had a significantly lower device success ra…

Study Presented of Embolic Protection Devices for SAVR

March 19, 2017 -- The American College of Cardiology (ACC) announced the presentation of a study demonstrating that two cerebral embolic protection devices that have been clea…

French Study Evaluates TAVR-Related Microbleeds

March 19, 2017 -- The American College of Cardiology (ACC) announced the results of a single-center study of 84 patients (age ≥ 80 years) undergoing transcatheter aort…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.